Reece share price spikes 4% despite 'year of disruption'

Reece posted earnings after the close yesterday.

| More on:
A woman looks unsure as she ladles mixture into a pan surrounded by small appliances

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Reece shares are on the move in early trade on Wednesday 
  • The moves come after the company posted its FY22 annual results after the bell yesterday 
  • In the last 12 months, the Reece share price is down more than 36% 

The Reece Ltd (ASX: REH) share price is lifting during the early hours of trading on Wednesday following the release of its FY22 results. At the time of writing, the Reece share price is up 3.59%, trading at $15.74.

The company actually posted its earnings after market hours yesterday, leaving investors to digest the news overnight and into this morning.

Reece share price lifts alongside revenue, profit

Key takeouts from the company's 12 months include:

What else happened for Reece last period?

There was growth from top-to-bottom throughout Reece's income statement for FY22. Revenue jumped 22% whilst NPAT followed suit with a 37% year-on-year gain.

In its Australia and New Zealand operations, sales revenue increased by 12% to $3.5 billion, up from $3.15 billion in FY21.

Meanwhile, Reece also continued its initiatives to bring the Reece brand into the US market, growing its footprint to 204 stores and refurbishing another 11 stores during the year. 

With the 37% gain in EPS, the board was able to authorise a final dividend of 15 cents per share, recorded on 12 October, payable on 26 October 2022.

Management commentary

Speaking on the results, Reece Group CEO, Peter Wilson said:

We have navigated another year of disruption and change in FY22 to deliver a very strong result, demonstrating the resilience of our business. Despite being hit by ongoing challenges, the team successfully navigated the ongoing pandemic, supply chain constraints and natural disasters to continue delivering for our customers, who were busier than ever.

Looking ahead, we believe we are past the peak of the cycle in our end markets and are prepared for
softening conditions. The macro setting is complex and will require careful management, but Reece has a strong track record of managing and investing to improve its business through the cycle.

Reece share price snapshot

In the last 12 months, the Reece share price is down more than 36% or 41% this year to date.

Despite its struggles, it has continued to gain over 8% in the past single month of trade.

Should you invest $1,000 in Medlab Clinical right now?

Before you buy Medlab Clinical shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Medlab Clinical wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Lines of codes and graphs in the background with woman looking at laptop trying to understand the data.
Earnings Results

Westpac share price sinks on half-year results miss

Let's see how the big four bank performed during the first half.

Read more »

Miner looking at a tablet.
Gold

Newmont share price lifts off on first-quarter results

The ASX 200 gold stock is charging higher on Thursday.

Read more »

A man wakes up happy with a smile on his face and arms outstretched.
Healthcare Shares

ResMed shares jump 8% on strong Q3 update

It was yet another strong quarter from this high-quality company.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Up 53% in a year, why is this ASX 200 financial stock leaping higher again today?

Investors are sending the ASX 200 financial stock soaring on Wednesday. Let’s see why.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Why is this ASX 200 uranium stock rocketing 17% on Wednesday?

The ASX 200 uranium stock is racing higher today. But why?

Read more »

Piggy bank at the end of a winding road.
Dividend Investing

Why this $44 billion ASX 200 dividend stock is pushing higher today

The ASX 200 dividend stock trades on a yield of 4.6%.

Read more »

Workers inspecting a gas pipeline.
Energy Shares

Why is the Santos share price racing ahead of the ASX 200 today?

Santos shares are enjoying a day of strong outperformance. But why?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Financial Shares

What's happening with the AMP share price on Thursday?

A lot of AMP shares are changing hands on Thursday. But at what price?

Read more »